The effect of ondansetron on reduction of etomidate-induced myoclonic movements
Phase 3
Recruiting
- Conditions
- etomidate-induced myoclonic movements.MyoclonusG25.3
- Registration Number
- IRCT20190510043545N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Adults (over 18 years old) ASA??-? who are candidates for elective ophthalmic surgery. And consent to participate in the study.
Exclusion Criteria
Patients with adrenal dysfunction
Drug allergy
Mental disorders
Neuromuscular disease
Seizures
Electrolyte disorders
Surgery with a high risk of nausea and vomiting such as strabismus
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of myoclonus. Timepoint: The occurrence and severity of myoclonus are controlled from the time of injection to 90 seconds after atomiditis injection. Method of measurement: myoclonic movements score.
- Secondary Outcome Measures
Name Time Method